TY - JOUR
T1 - Favorable resuscitation characteristics in patients undergoing extracorporeal cardiopulmonary resuscitation: A secondary analysis of the INCEPTION-trial
T2 - Resuscitation Plus
AU - Ubben, J.F.H.
AU - Heuts, S.
AU - Delnoij, T.S.R.
AU - Suverein, M.M.
AU - Hermanides, R.C.
AU - Otterspoor, L.C.
AU - Kraemer, C.V.E.
AU - Vlaar, A.P.J.
AU - van der Heijden, J.J.
AU - Scholten, E.
AU - den Uil, C.
AU - Dos Reis Miranda, D.
AU - Akin, S.
AU - de Metz, J.
AU - van der Horst, I.C.C.
AU - Winkens, B.
AU - Maessen, J.G.
AU - Lorusso, R.
AU - van de Poll, M.C.G.
N1 - Export Date: 25 February 2025; Cited By: 1; Correspondence Address: J.F.H. Ubben; Department of Anesthesiology and Pain Medicine, Maastricht University Medical Center+, Maastricht, P. Debyelaan 25, 6229HX, Netherlands; email: [email protected]
PY - 2024
Y1 - 2024
N2 - Introduction: Extracorporeal cardiopulmonary resuscitation (ECPR) is increasingly used as a supportive treatment for refractory out-of-hospital cardiac arrest (OHCA). Still, there is a paucity of data evaluating favorable and unfavorable prognostic characteristics in patients considered for ECPR. Methods: We performed a previously unplanned post-hoc analysis of the multicenter randomized controlled INCEPTION-trial. The study group consisted of patients receiving ECPR, irrespective of initial group randomization. The patients were divided into favorable survivors (cerebral performance category [CPC] 1–2) and unfavorable or non-survivors (CPC 3–5). Results: In the initial INCEPTION-trial, 134 patients were randomized. ECPR treatment was started in 46 (66%) of 70 patients in the ECPR treatment arm and 3 (4%) of 74 patients in the conventional treatment arm. No statistically significant differences in baseline characteristics, medical history, or causes of arrest were observed between survivors (n = 5) and non-survivors (n = 44). More patients in the surviving group had a shockable rhythm at the time of cannulation (60% vs. 14%, p = 0.037), underwent more defibrillation attempts (13 vs. 6, p = 0.002), and received higher dosages of amiodarone (450 mg vs 375 mg, p = 0.047) despite similar durations of resuscitation maneuvers. Furthermore, non-survivors more frequently had post-ECPR implantation adverse events. Conclusion: The persistence of ventricular arrhythmia is a favorable prognostic factor in patients with refractory OHCA undergoing an ECPR-based treatment. Future studies are warranted to confirm this finding and to establish additional prognostic factors. Clinical trial Registration: clinicaltrials.gov registration number NCT03101787 © 2024 The Author(s)
AB - Introduction: Extracorporeal cardiopulmonary resuscitation (ECPR) is increasingly used as a supportive treatment for refractory out-of-hospital cardiac arrest (OHCA). Still, there is a paucity of data evaluating favorable and unfavorable prognostic characteristics in patients considered for ECPR. Methods: We performed a previously unplanned post-hoc analysis of the multicenter randomized controlled INCEPTION-trial. The study group consisted of patients receiving ECPR, irrespective of initial group randomization. The patients were divided into favorable survivors (cerebral performance category [CPC] 1–2) and unfavorable or non-survivors (CPC 3–5). Results: In the initial INCEPTION-trial, 134 patients were randomized. ECPR treatment was started in 46 (66%) of 70 patients in the ECPR treatment arm and 3 (4%) of 74 patients in the conventional treatment arm. No statistically significant differences in baseline characteristics, medical history, or causes of arrest were observed between survivors (n = 5) and non-survivors (n = 44). More patients in the surviving group had a shockable rhythm at the time of cannulation (60% vs. 14%, p = 0.037), underwent more defibrillation attempts (13 vs. 6, p = 0.002), and received higher dosages of amiodarone (450 mg vs 375 mg, p = 0.047) despite similar durations of resuscitation maneuvers. Furthermore, non-survivors more frequently had post-ECPR implantation adverse events. Conclusion: The persistence of ventricular arrhythmia is a favorable prognostic factor in patients with refractory OHCA undergoing an ECPR-based treatment. Future studies are warranted to confirm this finding and to establish additional prognostic factors. Clinical trial Registration: clinicaltrials.gov registration number NCT03101787 © 2024 The Author(s)
KW - ECPR
KW - OHCA
KW - Prognostic factors
KW - Refractory Arrest
KW - Resuscitation
KW - Ventricular Arrhytmias
U2 - 10.1016/j.resplu.2024.100657
DO - 10.1016/j.resplu.2024.100657
M3 - Article
C2 - 38778803
SN - 2666-5204
VL - 18
JO - Resusc. Plus
JF - Resusc. Plus
ER -